Déclenchement par agonistes de la GnRH ou hCG et soutien de la phase lutéale dans les cycles sous antagonistes de la GnRH - Onset and maintenance of the luteal phase with GnRH antagonists or hCG in cycles under GnRH antagonists
Olivennes, F.
Journal de Gynecologie Obstetrique et Biologie de la Reproduction 33(6): 3S 24-3S 26
2004
ISSN/ISBN: 0368-2315 Document Number: 380954
Document emailed within 1 workday
Related Documents
Wei, A.Y.; Mijal, K.A.; Christianson, M.S.; Schouweiler, C.M.; Lindheim, S.R. 2008: Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles Journal of Reproductive Medicine 53(3): 147-150Schuiling, G.A.; Valkhof, N.; Koiter, T.R. 1988: Effect of estradiol on the secretion of LH in the GnRH-pretreated rat after treatment with the GnRH-antagonist, Org 30093 Acta Endocrinologica 119(4): 582-588
Rudolf, K.; Kunkel, S.; Rudolf, H. 1987: Results of the GnRH-TRH and arginine-GnRH-TRH test in females with hyperprolactinemic galactorrhea Zentralblatt für Gynakologie 109(8): 501-509
Grzechocińska, B.; Fracki, S.ła.; Marianowski, P.; Dworniak, T.; Bablok, L.; Marianowski, L. 2003: Protocol of GNRH antagonist in poor responders in IVF-ET cycles Ginekologia Polska 74(9): 943-948
Olivennes, F.; Fanchin, R.; Lédée, N.; Righini, C.; Frydman, R. 2000: GnRH antagonists: yes or no? Gynecologie Obstetrique and Fertilite 28(4): 344-347
Olivennes, F. 2002: LH and GnRH antagonists Journal de Gynecologie Obstetrique et Biologie de la Reproduction 31(2 Part 2): 1s25
Olivennes, F.; Rongières, C.; Fanchin, R.; Frydman, R. 1998: Perspectives in the use of GnRh antagonists Contraception Fertilite Sexualite 26(3): 187-188
Kim, C.-H.; Jeon, G.-H.; Cheon, Y.-P.; Jeon, I.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2009: Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection Fertility and Sterility 92(5): 1758-1760
Marci, R.; Graziano, A.; Lo Monte, G.; Piva, I.; Soave, I.; Marra, E.; Lisi, F.; Moscarini, M.; Caserta, D. 2013: GnRH antagonists in assisted reproductive techniques: a review on the Italian experience European Review for Medical and Pharmacological Sciences 17(7): 853-873
Dahl, K.D.; Bicsak, T.A.; Hsueh, A.J. 1988: Naturally occurring antihormones: secretion of FSH antagonists by women treated with a GnRH analog Science 239(4835): 72-74
De Falco, M.; Pollio, F.; Pontillo, M.; Ambrosino, E.; Busiello, A.; Carbone, I.F.; Ciociola, F.; Di Nardo, M.A.; Landi, L.; Di Lieto, A. 2006: GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review Minerva Ginecologica 58(6): 553-560
Ozmen, B.; Sükür, Y.E.; Seval, M.M.; Ateş, C.; Atabekoğlu, C.S.; Sönmezer, M.; Berker, B. 2014: Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection European Journal of Obstetrics Gynecology and Reproductive Biology 183: 137-140
Griesinger, G.; Venetis, C.A.; Tarlatzis, B.; Kolibianakis, E.M. 2015: To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already! Reproductive Biomedicine Online 31(1): 6-8
Orvieto, R. 2015: To pill or not to pill in GnRH antagonist cycles: what should be the appropriate wash-out period? Reproductive Biomedicine Online 30(5): 557
Garcia-Velasco, J.A.; Fatemi, H. 2015: To pill or not to pill in GnRH-antagonist cycles: still an open debate Reproductive Biomedicine Online 31(3): 445
Garcia-Velasco, J.A.; Fatemi, H.M. 2015: To pill or not to pill in GnRH antagonist cycles: that is the question! Reproductive Biomedicine Online 30(1): 39-42
Steward, R.G.; Zhang, C.E.; Shah, A.A.; Yeh, J.S.; Chen, C.; Li, Y.-J.; Price, T.M.; Muasher, S.J. 2015: High Peak Estradiol Predicts Higher Miscarriage and Lower Live Birth Rates in High Responders Triggered with a GnRH Agonist in IVF/ICSi Cycles Journal of Reproductive Medicine 60(11-12): 463-470
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Borini, A.; Trevisi, M.R.; Bafaro, M.G.; Cattoli, M.; Bianchi, L.; Flamigni, C. 1995: Controlled ovarian hyperstimulation in women > or = 40 years old undergoing IVF-ET: mid-luteal versus early follicular (flare-up) GnRH analog regimens Acta Europaea Fertilitatis 26(2): 59-61
Behringer, K.; Wildt, L.; Mueller, H.; Mattle, V.; Ganitis, P.; van den Hoonaard, B.; Ott, H.W.; Hofer, S.; Pluetschow, A.; Diehl, V.; Engert, A.; Borchmann, P. 2010: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase Ii trial from the German Hodgkin Study Group Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(10): 2052-2060